Using healthcare claims data to analyze the prevalence of BCR‐ABL‐positive chronic myeloid leukemia in France: A nationwide population‐based study

BACKGROUND: Data on Chronic Myeloid Leukemia (CML) prevalence are scarce. Here we provide an estimation of the prevalence of CML in France for the year 2014 using French national health insurance data. METHODS: We selected patients claiming reimbursement for tyrosine kinase inhibitors (TKI) or with...

Descripción completa

Detalles Bibliográficos
Autores principales: Foulon, Stéphanie, Cony‐Makhoul, Pascale, Guerci‐Bresler, Agnès, Delord, Marc, Solary, Eric, Monnereau, Alain, Bonastre, Julia, Tubert‐Bitter, Pascale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558491/
https://www.ncbi.nlm.nih.gov/pubmed/31038849
http://dx.doi.org/10.1002/cam4.2200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558491/
https://www.ncbi.nlm.nih.gov/pubmed/31038849
http://dx.doi.org/10.1002/cam4.2200

Ejemplares similares